Select a month January 2004 December 2003 November 2003" October 2003 September 2003 July 2003 June 2003 May 2003 April 2003 March 2003 February 2003 January 2003 December 2002 November 2002 October 2002 September 2002 August 2002 July 2002 June 2002 May 2002 April 2002 March 2002 February 2002 January 2002 December 2001 November 2001 October 2001

Non-Human/In-Vitro Studies: Behavioral Pharmacology (Definition) Jump to: 2003: January  |  February  |  March  |  April  |   May  |   June  |   July  |   2002: January  |  February  |  March  |  April  |  May  |  June  |  July  |  August  |  September  |  October  |  November  |  December   2001: October  |  November  |  December July 2003 Timar J, Gyarmati S, Szabo A, Furst S. (2003) Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives. Behav Pharmacol 14:199-206. June 2003 Schenk S, Gittings D, Johnstone M, Daniela E (2003) Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169: 21-27. Won M, Minabe Y, Tani K, Suzuki K, Kawai M, Sekine Y, Ashby CR, Takei N, Mori N (2003) The effects of dentate granule cell destruction on behavioral activity and Fos protein expression induced by systemic MDMA in rats. Neurosci Res 46: 153-160. May 2003 No updates available for May 2003 April 2003 Goodwin AK, Pynnonen DM, Baker LE (2003) Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination. Pharmacol Biochem Behav 74: 987-995. March 2003 Zhou W, Cunningham KA, Thomas ML (2003) Estrogen effects on the hyperactivity induced by (+)-MDMA and cocaine in female rats. Behav Neurosci 117: 84-94 February 2003 Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH (2003) Pharmacological characterization of the effects of 3,4- methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology 1:1 Fernandez F, Porras G, Mormede P, Spampinato U, Chaouloff F (2003) Effects of 3,4-methylenedioxymethamphetamine on locomotor activity and extracellular dopamine in the nucleus accumbens of Fischer 344 and Lewis rats. Neurosci Lett 335: 212-216. January 2003 No updates available for January 2003 Demceber 2002 Navarro JF, Maldonado E (2002) Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze. Prog Neuropsychopharmacol Biol Psychiatry 26: 1151-1154. November 2002 No updates available for November 2002 October 2002 Meyer A, Mayerhofer A, Kovar K, Schmidt W (2002b) Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats. Neurosci Lett 330: 280-284. September 2002 Goodwin AK, Baker LE (2002). An analysis of the utility of differential outcome procedures in drug discrimination research. Behav Pharmacol 13: 271-278. August 2002 Braida D, Sala M (2002) Role of the endocannabinoid system in MDMA intracerebral self- administration in rats. Br J Pharmacol 136: 1089-1092. Fletcher PJ, Korth KM, Robinson SR, Baker GB (2002) Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology (Berl) 162: 282-91. July 2002 Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G (2002) 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology (Berl) 161: 356-64. June 2002 No updates available for June 2002 May 2002 Braida D, Pozzi M, Cavallini R, Sala M (2002). 3,4 methylenedioxymethamphetamine (ecstasy) impairs eight-arm radial maze performance and arm entry pattern in rats. Behav Neurosci 116: 298-304 April 2002 Glennon RA, Young R, Rangisetty JB (2002). Further characterization of the stimulus properties of 5,6,7,8- tetrahydro-1,3-dioxolo[4,5-g]isoquinoline. Pharmacol Biochem Behav 72: 379-387 March 2002 No updates available for March 2002 February 2002 Bankson, MG, Cunningham KA (2002). Pharmacological Studies of the Acute Effects of (+)-3,4- Methylenedioxymethamphetamine on Locomotor Activity. Role of 5- HT(1B/1D) and 5-HT(2) Receptors. Neuropsychopharmacology 26: 40-52 Young R, Glennon RA (2002). The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5- g]isoquinoline is similar to that of cocaine but different from that of amphetamine. Pharmacol Biochem Behav 71: 205-213 January 2002 No updates available for January 2002 December 2001 Hong SS, Young R, Glennon RA (2001). Discriminative stimulus properties of alpha-ethyltryptamine optical isomers. Pharmacol Biochem Behav 70: 311-6 November 2001 No updates available for November 2001 October 2001 Taylor, JR and Jentsch, D (2001). Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behavior in rats: Differential effects of cocaine, d-amphetamine and 3,4-methylenedioxymethamphetamine ("Ecstasy"). Biological Psychiatry, 50: 137-143.